InvestSMART

Anagenics Limited (ASX:AN1)

ALERT: Price-sensitive ASX Announcement for AN1
Current share price for AN1 : $0.007 0.001 (16.67%)+
Announcement
Release
27 Apr 2026 10:31AM
Price at Release
$0.006
Full Release
download
Summary
Anagenics Limited, trading as ASX: AN1, reported its Q3 FY2026 financial performance with operating cash outflows of $0.3 million, totaling $1.0 million for the nine months ending March 2026. The company anticipates an improvement in cash flow from operations in the second half of FY2026. BLC Cosmetics, Anagenics' subsidiary, is now trading profitably post-restructuring. York Street Brands' Bouf Haircare continued to perform strongly, generating substantial royalty revenues. The report highlighted a net financing cash inflow of $924,000, emphasizing Anagenics' strategic focus on its proprietary and licensed anti-aging solutions.
Key Points
  • Anagenics Limited experienced operating cash outflows of $0.3 million in Q3 FY2026, totaling $1.0 million for the nine months ending March 2026.
  • The negative cash flow was primarily due to resolving outstanding creditor payments, with anticipated improvements in cash flow expected in the second half of FY2026.
  • BLC Cosmetics, a subsidiary of Anagenics, has been restructured and is now trading profitably, with plans to expand its product portfolio.
  • York Street Brands' Bouf Haircare, developed using Anagenics' proprietary technology, continued strong performance with royalty revenue of $347,000 in Q3 FY2026.
  • Anagenics has invoiced $738,000 in royalty revenue for the nine months ending March 2026.
  • The company reported a net cash inflow from financing activities amounting to $924,000 for the quarter.
  • Anagenics is focused on growing shareholder value through the global distribution and sales of its proprietary and licensed brands.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.